Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EPOCH-R for Relapsed AIDS-Associated Lymphoma
NCT00001563Phase 2Completed
- Sponsor
- National Cancer Institute
- Start
- Jan 1997
- Primary completion
- May 2005
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of rituximab in AIDS-related lymphoma, sponsored by National Cancer Institute. Started Jan 1997; status: completed.
02
Drugs
rituximab
03
Conditions
AIDS-related lymphoma
Beyond the preview
Go deeper on NCT00001563.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00001563.